Veterinary Infectious Disease Diagnostics Market Expands Rapidly With Support From Growing Zoonotic Threats and Increased Pet Care Awareness

"Veterinary Infectious Disease Diagnostics Market" in terms of revenue was estimated to be worth USD 2.06 billion in 2023 and is poised to reach USD 3.95 billion by the year 2031, growing at a CAGR of 8.69% from 2024 to 2031 according to a new report by InsightAce Analytic.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1488

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the veterinary infectious disease diagnostics market are:
• Rising rates of zoonotic and transboundary diseases
• Increase in research and development efforts
• The increased popularity of owning pets

The following are the primary obstacles to the veterinary infectious disease diagnostics market 's expansion:
• Growing expenses for pet care
• Veterinarians in short supply in emerging markets
• Insufficient diagnostic facilities

Future expansion opportunities for the veterinary infectious disease diagnostics market include:
• Increasingly popular pet insurance
• Increasing spending on animal healthcare
• Technological Advancement

Market Analysis:
Veterinary infectious disease diagnostics refers to the range of methods and tests used to detect and identify contagious diseases in animals. These diagnostic procedures are designed to identify pathogens such as parasites, viruses, and bacteria that contribute to animal illnesses. The increasing demand for diagnostic testing among pet and livestock owners has led to a rise in associated healthcare costs. As a result, the market is poised for significant growth in the coming years. Additionally, the regional market is experiencing favorable performance, supported by ongoing research and development initiatives and the availability of advanced, high-quality veterinary healthcare infrastructure.

List of Prominent Players in the Veterinary Infectious Disease Diagnostics Market:
• BIOMÉRIEUX (France)
• Heska Corporation (U.S.)
• IDEXX (U.S.)
• Neogen Corporation (U.S.)
• INDICAL BIOSCIENCE GmbH (Germany)
• Randox Laboratories Ltd. (U.K.)
• Thermo Fisher Scientific Inc. (U.S.)
• Virbac (France)
• Zoetis (U.S.)
• Creative Diagnostics (U.S.)
• DRG INSTRUMENTS GMBH (Germany)
• Chembio Diagnostic Systems, Inc. (U.S.)
• Eurofins Technologies (Luxembourg)
• Abaxis (U.S.)
• Agrolabo S.p.A. (Italy)
• Abbott (U.S.)
• Danaher (U.S.)

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Recent Developments:
• In January 2024, IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, unveiled the IDEXX in Vue DxTM Cellular Analyzer. This revolutionary device is the first of its kind and can diagnose the most common cytologic abnormalities found in blood and ear samples.
• In January 2024, Neogen Corporation introduced the SureKill Gel Bait Pro Applicator, the newest SureKill line of pest control solutions member.
• In June 2023, Chembio Diagnostics, Inc., a front-runner in infectious disease point-of-care diagnostics, announced that it had received a Clinical Laboratory Improvement Amendments (CLIA) waiver for the DPP HIV-Syphilis System from the U.S. Food and Drug Administration (FDA).

Veterinary Infectious Disease Diagnostics Market Dynamics:
Market Drivers: Rising Pet Ownership and Demand for Animal Healthcare
The veterinary infectious disease diagnostics market is experiencing growth driven by the increasing global pet population and the rising demand for related care products and services. Key factors contributing to market expansion include the growing consumption of animal-derived food products, an increasing number of veterinary professionals, heightened efforts to prevent and control infectious diseases, a surge in companion animal ownership, and the availability of favorable pet insurance policies. These trends collectively support the ongoing development of the market.

Challenges: Escalating Pet Healthcare Costs
Despite positive momentum, the market faces several growth barriers, particularly the escalating costs associated with pet healthcare. These rising expenses are largely attributed to the increased frequency of veterinary consultations required for effective disease management. In developing regions, limited awareness of animal health and the shortage of trained veterinary professionals further constrain market growth. High veterinary care costs also reduce the frequency of visits to animal healthcare facilities, presenting a significant challenge to market expansion, especially in emerging economies.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1488

North America is Expected to Grow with the Highest CAGR During the Forecast Period
The veterinary infectious disease diagnostics market is expected to capture a substantial revenue share and experience robust compound annual growth in the coming years. This growth is primarily driven by the increased availability of diagnostic products, rising pet ownership rates, and higher expenditure on animal healthcare. Additionally, the regional market expansion is supported by ongoing research and development efforts and the presence of advanced healthcare infrastructure.

Segmentation of Veterinary Infectious Disease Diagnostics Market-
By Technology-
• Immunodiagnostics
o Lateral Flow Assays
o ELISA Test
o Other Immunodiagnostics Products
• Molecular Diagnotic
o Polymerase Chain Reaction (PCR) Tests
o Microarrays
o Other Molecular Diagnostic Products
• Other Technologies
By Animal Type-
• Companion Animals
o Cats
o Dogs
o Horses
o Other Companion Animals
• Companion Animals By Infection Type
o Viral Infections
o Bacterial Infections
o Parasitic Infections
o Other Infections
• Food -producing Animals
o Cattle
o Pigs
o Poultry
o Other Food-producing animals
• Food-producing Animals, By Infection Type
o Viral Infections
o Bacterial Infections
o Parasitic Infections
o Other Infections
By End User-
• Reference Laboratories
• Veterinary Hospitals and Clinics
• Point-of-care/ In-house testing
• Research Institutes and Universities
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/global-veterinary-infectious-disease-diagnostics-market/1488

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.